Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hemagen financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$387.5 K
2024-10-29
Revenue
$4 M
FY, 2012
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 |
|---|---|---|
| Revenue | 5.1M | 4.0M |
| Cost of goods sold | 3.2M | 2.4M |
| Gross profit | 2.0M | 1.6M |
| Gross profit margin, % | 38.1% | 39.9% |
| General and administrative expense | 2.4M | 2.0M |
| Operating expense total | 2.4M | 2.1M |
| EBIT | (472.7K) | (437.9K) |
| EBIT margin, % | -9.2% | -10.8% |
| Interest expense | 406.6K | 469.2K |
| Pre tax profit | (876.3K) | (907.3K) |
| Income tax expense | (4.1K) | |
| Net Income | (880.5K) | (907.3K) |
| EPS | (0.1) | (0.1) |